LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

Home・Akciju saraksts・SIGA Technologies Inc

SIGA Technologies Inc

Slēgts

SektorsVeselības aprūpe

6.54 1.24

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

6.29

Max

6.64

Galvenie mērījumi
By Trading Economics
Ienākumi	-42M -6.4M
Pārdošana	-79M 2.6M
P/E Sektora vidējais	6.515 108.767
EPS	-0.089
Peļņas marža	-242.97
Darbinieki	46
EBITDA	-56M -8.2M

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 10. marts

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-107M 481M
Iepriekšējā atvēršanas cena	5.3
Iepriekšējā slēgšanas cena	6.54

Ziņu noskaņojums

By Acuity

43%

57%

132 / 352 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

5.41 / 5.63 Atbalsts un pretestība

SIGA Technologies Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 2. marts 23:41 UTC

Tirgus saruna

Galvenie ziņu notikumi

Nikkei May Decline on Concerns About Energy Prices -- Market Talk

2026. g. 2. marts 23:37 UTC

Tirgus saruna

Galvenie ziņu notikumi

Gold Edges Higher Amid Middle East Conflict -- Market Talk

2026. g. 2. marts 23:26 UTC

Galvenie ziņu notikumi

How the Iran Conflict Could Pressure Consumer Staples Companies -- Barrons.com

2026. g. 2. marts 22:41 UTC

Tirgus saruna

Australian Reits Wait on Recovery in Trading Multiples -- Market Talk

2026. g. 2. marts 22:32 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 2. marts 22:32 UTC

Tirgus saruna

RBA Cautious About Potential for Energy Supply Shocks -- Market Talk

2026. g. 2. marts 22:21 UTC

Tirgus saruna

Port of Tauranga's Upgraded Profit View Still Looks Conservative -- Market Talk

2026. g. 2. marts 22:11 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 2. marts 22:11 UTC

Tirgus saruna

Don't Lose Sight of Bigger Picture With Summerset -- Market Talk

2026. g. 2. marts 22:10 UTC

Iegādes, apvienošanās, pārņemšana

IAC Is Near Deal to Sell Care.com to Private-Equity Firm -- WSJ

2026. g. 2. marts 22:06 UTC

Tirgus saruna

Channel Infrastructure's Dividend Positively Surprises -- Market Talk

2026. g. 2. marts 22:00 UTC

Tirgus saruna

Peļņas

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 2. marts 22:00 UTC

Tirgus saruna

Peļņas

Fashion Retailer Hallenstein Glasson Still a Smart Buy -- Market Talk

2026. g. 2. marts 21:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Energy & Utilities Roundup: Market Talk

2026. g. 2. marts 21:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 2. marts 21:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 2. marts 21:35 UTC

Iegādes, apvienošanās, pārņemšana

AT&T Expects Net Debt-To-Adjusted Ebitda Ratio Will Rise to About 3.2x Following Deal With EchoStar and Decline to About 3x by End of 2026

2026. g. 2. marts 21:34 UTC

Iegādes, apvienošanās, pārņemšana

AT&T Remains on Track to Achieve Its 2026 and Multi-Yr Fincl Guidance

2026. g. 2. marts 21:30 UTC

Iegādes, apvienošanās, pārņemšana

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2026. g. 2. marts 21:17 UTC

Galvenie ziņu notikumi

Bank, Brokerage Stocks Recover Lost Ground After Last Week's Selloff -- Despite Iran Conflict -- Barrons.com

2026. g. 2. marts 20:44 UTC

Peļņas

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2026. g. 2. marts 20:43 UTC

Tirgus saruna

Galvenie ziņu notikumi

Treasury Yields Fall, Dollar Strengthens After Attack on Iran -- Market Talk

2026. g. 2. marts 20:28 UTC

Peļņas

Strategy Stock Rises. The World's Largest Bitcoin Holder Doubles Down on Its Crypto Bet. -- Barrons.com

2026. g. 2. marts 20:25 UTC

Tirgus saruna

Galvenie ziņu notikumi

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

2026. g. 2. marts 20:24 UTC

Peļņas

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2026. g. 2. marts 20:14 UTC

Iegādes, apvienošanās, pārņemšana

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2026. g. 2. marts 20:12 UTC

Galvenie ziņu notikumi

Palantir Rises on Mideast Conflict. Why It's Moving Like a Defense Stock. -- Barrons.com

2026. g. 2. marts 20:08 UTC

Tirgus saruna

Galvenie ziņu notikumi

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 2. marts 20:08 UTC

Tirgus saruna

Galvenie ziņu notikumi

Higher Oil Prices Could Boost Capex in Canada Energy Patch -- Market Talk

2026. g. 2. marts 20:05 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Rises On U.S.-Middle East Conflict, But Settles Off Highs -- Market Talk

Salīdzinājums

Cenas izmaiņa

SIGA Technologies Inc Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 0 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam SIGA Technologies Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

5.41 / 5.63Atbalsts un pretestība

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Noskaņojums

By Acuity

132 / 352 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par SIGA Technologies Inc

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.